Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001824293-25-000153
Filing Date
2025-11-14
Accepted
2025-11-14 07:47:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 prossuppno2april25s-1.htm 424B3 515330
2 GRAPHIC gri_logoselectxcolorjpg.jpg GRAPHIC 221425
3 GRAPHIC image_0.jpg GRAPHIC 12244
  Complete submission text file 0001824293-25-000153.txt   813126
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI Bio, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-286072 | Film No.: 251481262
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)